Patents Assigned to URIGEN N.A.
  • TREATMENT OF LOWER URINARY TRACT EPITHELIUM WITH GLUCAGON LIKE PEPTIDE 2
    Publication number: 20240148834
    Abstract: The present invention provides a method for treating and/or ameliorating a disorder of the lower urinary tract, comprising administering a composition comprising a glucagon like peptide 2 (GLP-2) receptor agonist to a patient in need thereof in an amount sufficient to treat and/or ameliorate the disorder of the lower urinary tract.
    Type: Application
    Filed: November 8, 2023
    Publication date: May 9, 2024
    Applicant: URIGEN N.A.
    Inventors: Christopher P. Meenan, C. Lowell Parsons, Daniel Vickery
  • Treatment of lower urinary tract epithelium with glucagon like peptide 2
    Patent number: 10925930
    Abstract: The present invention provides a method for treating and/or ameliorating a disorder of the lower urinary tract, comprising administering a composition comprising a glucagon like peptide 2 (GLP-2) receptor agonist to a patient in need thereof in an amount sufficient to treat and/or ameliorate the disorder of the lower urinary tract.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: February 23, 2021
    Assignee: URIGEN N.A.
    Inventors: Christopher P. Meenan, C. Lowell Parsons, Daniel Vickery